Health
Targeted treatments for EGFR-positive lung cancer can improve outcomes – Medical News Today
Targeted therapies are available for people with EGFR mutations, and they tend to be more effective. Learn more about the treatment…
EGFR mutations account for about 1015% of lung cancer cases in the United States. Biomarker testing allows oncologists to choose targeted treatments for these types of lung cancer.
Non-small cell lung cancer (NSCLC) accounts for about 85%
of lung cancer…
Continue Reading
-
General22 hours agoBill Shorten believes Peter Dutton’s work-from-home policy backflip will cost him at election time
-
General24 hours agoOh, for the good old days? • Inside Story
-
Noosa News23 hours agoAustralia faces Kazakhstan in Billie Jean King Cup qualifier at Pat Rafter Arena
-
General23 hours agoAustralia looks to Asia, Europe amid US tariff turmoil